Essex Bio-Technology Limited (01061.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 2.10

From 52W high−59.12%

Volume493000.00

Market capHKD 1.28B

P/E (TTM)4.8x

P/S (TTM)0.7x

Div yield5.30%

Key dataSep 18, 2026

Open

HKD 2.10

From 52W high

−59.12%

Volume

493000.00

Market cap

HKD 1.28B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.1x

P/E (TTM)

4.8x

RSI (14)

53.7

MomentumView details →

1D Return

+8.11%

YTD Return

−39.92%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

4.8x

EV/EBITDA

2.1x

EV/Sales

0.5x

P/S (TTM)

0.7x

P/B (TTM)

0.5x

ProfitabilityView details →

Gross Margin

86.85%

Net Margin

15.41%

EBITDA Margin

23.29%

ROE (TTM)

10.41%

ROA (TTM)

7.34%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

−0.74%

EPS YoY

−14.55%

FCF YoY

−39.39%

Revenue CAGR 3Y

+11.24%

EPS CAGR 3Y

+12.82%

EBITDA YoY

−7.94%

MomentumView details →

1D Return

+8.11%

YTD Return

−39.92%

1Y Return

−57.02%

RSI (14)

53.7

vs 50D SMA

−4.39%

vs 200D SMA

−30.94%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

2.15x

Quick Ratio

2.04x

Div Yield

5.30%

Div Rate

HKD 0.12

Div Growth 1Y

−7.69%

EarningsView details →

EPS (Actual)

HKD 0.20

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

3.46B

Net Income (TTM)

578.59M

Op. CF (TTM)

646.37M

Next earningsMar 11, 2027 →

Latest newsMore news →

Essex Bio-Technology declared an interim dividend of HK$0.05 per share for the six months ended June 2026, down from HK$0.07 in the prior year period.46d ago

Essex Bio-Technology reported interim results for the six months ended June 2026, with revenue of HK$785 million, down 10.5% year-on-year, and net profit of HK$111 million, down 32.2%.46d ago

Similar companies

Harrow Health, Inc.HROW Jilin Province Huinan Changlong Bio-pharmacy Company Limited08049.HK JBM (Healthcare) Limited02161.HK Cronos Group Inc.CRON Phibro Animal Health CorporationPAHC Golden Throat Holdings Group Company Limited06896.HK Find similar companies →

Latest newsMore news →

Essex Bio-Technology declared an interim dividend of HK$0.05 per share for the six months ended June 2026, down from HK$0.07 in the prior year period.46d ago Essex Bio-Technology reported interim results for the six months ended June 2026, with revenue of HK$785 million, down 10.5% year-on-year, and net profit of HK$111 million, down 32.2%.46d ago Yisheng Bio (01061) entered into a strategic cooperation framework agreement with Kureha Medical to expand their collaboration in regenerative medicine and wound repair across China, Southeast Asia, and Japan.59d ago